Madrid, Spain

Alma Maria Jimenez-Aguado

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Alcobendas, ES (2010)
  • Madrid, ES (2012)

Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alma Maria Jimenez-Aguado: Innovator in Pharmaceutical Patents from Madrid

Introduction

Alma Maria Jimenez-Aguado is a prominent inventor based in Madrid, Spain, recognized for her significant contributions in the field of pharmaceuticals. With two patents to her name, she has focused on developing novel compounds that aim to improve treatments for various mental health conditions.

Latest Patents

Her latest patents include innovative compounds that have the potential to be groundbreaking in medical science. The first patent, titled "Spiropiperidine compounds as ORL-1 receptor antagonists," describes an antagonist of the ORL-1 receptor along with its uses and methods for preparation. This compound focuses on advancing treatment strategies for specific neurological challenges. Her second patent addresses "Thiophene and furan compounds," which relates to the development of thiophene and furan compounds, including their pharmaceutically acceptable salts. This invention looks to provide therapeutic options for conditions such as schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, and depression.

Career Highlights

Alma works at Eli Lilly and Company, a global leader in the pharmaceutical industry. Her role allows her to apply her innovative mindset in researching and developing effective therapies that address unmet medical needs. Through her career, she has been recognized for her dedication to advancing science and improving patient outcomes.

Collaborations

In her professional journey, Alma collaborates with esteemed colleagues, including Ana Belen Benito Collado and Nuria Diaz Buezo, who share her commitment to pushing the boundaries of pharmaceutical research. Together, they work towards discovering new solutions that can potentially transform patient care.

Conclusion

Alma Maria Jimenez-Aguado's work exemplifies the vital intersection of innovation and healthcare. With her pioneering patents and collaborative efforts at Eli Lilly and Company, she continues to make strides that may change the landscape of treatments for various neurological and psychiatric conditions. Her contributions highlight the importance of ongoing research and innovation in the quest for better health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…